Neurology Diagnostic and Monitoring Devices Market Report 2025

This neurology diagnostic and monitoring devices market report delivers an in-depth analysis of the market’s key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market across major regions and leading countries, highlighting historical data and future growth projections. The report also examines the competitive landscape, market share insights, emerging trends, and strategic developments shaping the market.

The neurology diagnostic and monitoring devices market size has grown strongly in recent years. It will grow from $8.52 billion in 2024 to $9.32 billion in 2025 at a compound annual growth rate (CAGR) of 9.4%. The growth in the historic period can be attributed to increasing healthcare spending and investment, an increase in EEG procedures, increasing healthcare expenditure, increasing investment in research and development, and improving diagnostic accuracy.

The neurology diagnostic and monitoring devices market size is expected to see strong growth in the next few years. It will grow to $13.21 billion in 2029 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to government and healthcare initiatives, the emergence of personalized medicine, the growth of telemedicine, expanding healthcare infrastructure, and regulatory approvals and standards. Major trends in the forecast period include telehealth expansion, advanced neurostimulation devices, biomarker discovery and integration, neuroinformatic and data integration, and nanotechnology developments.

The increasing prevalence of neurodegenerative diseases is projected to drive the growth of the neurology diagnostic and monitoring devices market in the future. Neurodegenerative diseases are a group of disorders characterized by the progressive degeneration or death of nerve cells (neurons) in the brain and/or spinal cord. The rise in these diseases is attributed to aging populations, increased life expectancy, and greater exposure to environmental and genetic risk factors. Neurology diagnostic and monitoring devices play a crucial role by providing precise and real-time assessments of brain function and disease progression, facilitating early diagnosis, customized treatment plans, and effective monitoring of therapeutic responses. For example, in September 2023, the National Records of Scotland reported that Alzheimer’s disease and other dementias caused 6,277 deaths in Scotland in 2022, a 4% increase from the previous year, which saw an additional 231 deaths. This rising prevalence of neurodegenerative diseases is driving market growth.

Leading companies in the neurology diagnostic and monitoring devices market are developing advanced solutions, such as image-guided therapy systems, to improve precision in neurovascular procedures. An image-guided therapy system is a medical technology used to aid in the planning, navigation, and execution of various therapeutic procedures, often in real-time. For instance, in February 2024, Koninklijke Philips N.V., a Netherlands-based health technology company, launched the Azurion neuro biplane system. This system enhances minimally invasive diagnosis and treatment of neurovascular patients with features such as improved C-arm rotation and angulation for better imaging flexibility, rapid switching between 2D and 3D imaging to optimize workflow, comprehensive table-side control to maintain a sterile field, automatic beam rotation for precise image orientation, a new head immobilizer for stroke patient care, and AI and machine learning integration for performance monitoring and issue prediction.

In July 2022, ArchiMed, a France-based investment firm, acquired Natus Medical for $1.2 billion. This acquisition aims to boost Natus Medical's capabilities by expanding the reach and breadth of its market-leading products, strengthening research and development efforts, and pursuing additional acquisitions of complementary businesses. Natus Medical Incorporated is a US-based provider of neurodiagnostic devices, including neurology diagnostic and monitoring devices.

Major companies operating in the neurology diagnostic and monitoring devices market are Siemens Healthineers, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Shimadzu Corporation, Masimo Corporation, Nihon Kohden Corporation, Elekta AB, Natus Medical Incorporated, Esaote S.p.A., Zynex Medical Inc., Canon Medical Systems Corporation, Neurosoft S.A., Cadwell Industries Inc., Cogito Brains Inc., Blackrock Neurotech Inc., Compumedics Limited, Ceribell Inc., Nexstim Plc, NeuroMetrix Inc., Lumos Labs Inc., Soterix Medical Inc., Advanced Brain Monitoring Inc., Sense Neuro Diagnostics Inc.

North America was the largest region in the neurology diagnostic and monitoring devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neurology diagnostic and monitoring devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the neurology diagnostic and monitoring devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Neurology diagnostic and monitoring devices are medical instruments used to diagnose and monitor disorders of the nervous system, including the brain, spinal cord, and peripheral nerves. These devices evaluate neurological functions and aid in detecting conditions such as epilepsy, stroke, Alzheimer's disease, and multiple sclerosis.

Key types of neurology diagnostic and monitoring devices include electroencephalogram (EEG) systems, magnetic resonance imaging (MRI) systems, computed tomography (CT) scanners, positron emission tomography (PET) systems, ultrasound imaging systems, and others. EEG systems, for example, measure and record electrical activity in the brain using electrodes placed on the scalp. These devices are utilized for diagnosing various conditions such as neurodegenerative diseases, epilepsy, stroke, and more. The primary users of these devices include hospitals and surgical centers, neurology centers, ambulatory care centers, diagnostic laboratories and imaging centers, as well as laboratories and academic institutions.

The neurology diagnostic and monitoring devices market research report is one of a series of new reports that provides neurology diagnostic and monitoring devices market statistics, including the neurology diagnostic and monitoring devices industry's global market size, regional shares, competitors with a neurology diagnostic and monitoring devices market share, detailed neurology diagnostic and monitoring devices market segments, market trends and opportunities, and any further data you may need to thrive in the neurology diagnostic and monitoring devices industry. This neurology diagnostic and monitoring devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The neurology diagnostic and monitoring devices market consists of sales of electromyography (EMG) systems, magnetoencephalography (MEG) systems, functional magnetic resonance imaging (fMRI) systems, and transcranial magnetic stimulation (TMS) systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.